Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report

Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report

Abstract Background While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is frequently undertaken in them. Although stent thrombosis remains a fatal complication in stent-b...

Full description

Bibliographic Details
Main Authors: Keisuke Shoji, Kan Zen, Takashi Ookura, Kenji Yanishi, Satoaki Matoba
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Stent thrombosis
Cancer
Coronary artery disease
Regorafenib
Vascular endothelial growth factor
Online Access:https://doi.org/10.1186/s12872-021-01888-9

Internet

https://doi.org/10.1186/s12872-021-01888-9

Similar Items